Masayoshi Son No Longer Asia’s 3rd Richest—After Softbank Sells Nvidia Stakehttps://t.co/gD9QiSArWY https://t.co/B3lEsSjK7G ...

Why is Softbank selling its entire stake in Nvidia now?Tom Mackenzie explains https://t.co/GH8axvXY7t https://t.co/WswQ9FHuIU ...

Core Insights - Softbank, the Japanese tech holding company led by Masayoshi Son, has divested its entire stake in Nvidia Corp, selling 100% of its shares [1] Company Summary - The decision to sell Nvidia shares indicates a strategic shift for Softbank, reflecting its approach to managing investments in the tech sector [1] - This move may impact Softbank's portfolio diversification and future investment strategies, as Nvidia has been a significant player in the semiconductor industry [1] Industry Summary - The sale of Nvidia shares by Softbank could signal changing dynamics in the tech investment landscape, particularly in the semiconductor market [1] - Investors may interpret this divestment as a response to market conditions or internal strategic realignments within Softbank [1]

Core Viewpoint - Marvell Technology's stock has experienced a significant recovery, rising from a low of $47 in April to a high of $92.90 recently, indicating strong market performance and investor confidence [1] Stock Performance - The stock price increased from $47 in April to a peak of $92.90, showcasing a robust rebound over the past few months [1]

Core Viewpoint - Intel has shown signs of recovery with better-than-expected third-quarter results, although revenue growth remains weak, indicating low market expectations [2]. Financial Performance - Revenue increased by 3% to $13.7 billion, surpassing the consensus estimate of $13.14 billion [2]. - Adjusted gross margin improved significantly by 22 percentage points to 40%, driven by a favorable product mix, reduced inventory reserves, and increased revenue [3]. - Operating margin rose by 29 percentage points to 11.2%, aided by a reduction in research and development and general and administrative expenses from $4.8 billion to $3.9 billion [3]. - Adjusted earnings per share reached $0.23, a turnaround from a loss of $0.46 per share in the same quarter last year [3]. Strategic Changes - CEO Lip-Bu Tan has focused on strengthening the balance sheet, raising $12.9 billion through various stake sales, including to the federal government, Nvidia, and Softbank [4]. - The company repaid $4.3 billion in debt and added $20 billion in net assets since the beginning of the year, reflecting the success of these initiatives [4]. - Intel has undergone significant restructuring, including job cuts and management refreshment, to foster an engineering-first mindset [6]. Future Outlook - For the fourth quarter, Intel anticipates revenue between $12.8 billion and $13.8 billion, representing a 3% sequential decline and a 6.3% year-over-year decline [7]. - Despite efforts to streamline operations, Intel continues to face growth challenges compared to competitors like Nvidia, AMD, and Arm, which are capitalizing on the AI boom [7].

Core Points - Afya Limited, a leading medical education group and medical practice solutions provider in Brazil, has announced a Share Repurchase Agreement with SBLA Holdco LLC, an affiliate of Softbank [1] - The agreement involves the repurchase of all 150,000 Series A Perpetual Convertible Preferred Shares, each with a nominal or par value of US$0.00005 [1]

Core Viewpoint - Intel Corporation is preparing for its third-quarter financial report, with expectations of a revenue decline compared to the previous year, while analysts predict a slight improvement in earnings per share [1][2]. Earnings Estimates - Analysts forecast Intel's Q3 revenue to be $13.14 billion, down from $13.28 billion in the same quarter last year [1]. - The expected earnings per share for Q3 is 1 cent, a significant recovery from a loss of 46 cents per share a year ago [2]. - Intel's guidance for Q3 revenue ranges from $12.6 billion to $13.6 billion, with a projected loss of 24 cents per share [3]. Analyst Insights - Intel has exceeded revenue estimates for four consecutive quarters and has beaten earnings estimates in seven of the last ten quarters overall [2]. - Wedbush analyst Matt Bryson suggests that Intel could show operational improvements and better guidance, maintaining a Neutral rating while raising the price target from $19 to $20 [4][5]. - Bank of America Securities analyst Vivek Arya downgraded Intel from Neutral to Underperform, citing market share losses to competitors and limited AI integration, with a price target of $34 [7]. Key Items to Watch - The prediction market indicates a strong belief (76%) that Intel will beat earnings per share estimates for Q3 [4]. - Analysts expect discussions around recent product announcements, including the Crescent Island GPU, which aims to enhance Intel's position in the AI chip market [9]. - Intel's Panther Lake processors are anticipated to begin shipping later this year, targeting growth in AI, gaming, and edge solutions sectors [10]. Price Action - Intel's stock has decreased by 3.5% to $36.78, with a year-to-date increase of 82.0% [10].

Not AI. #BNB🤝🇯🇵 https://t.co/Hzd4DWiYtlCZ 🔶 BNB (@cz_binance):Softbank & PayPay invests 40% in Binance Japanhttps://t.co/To6pnzeTfm ...

Softbank & PayPay invests 40% in Binance Japanhttps://t.co/To6pnzeTfm ...

Market Overview - International equities showed mixed results in Q3 2025, with the MSCI EAFE Index rising 4.8%, driven by Asian markets and Canada, while Europe Ex U.K. underperformed [3] - The MSCI Emerging Markets Index advanced 10.6%, supported by a 20.7% rally in China, which constitutes 30% of that benchmark [3] - European markets experienced a slowdown in momentum due to inflation remaining above the European Central Bank's target, with a September reading of 2.2% [4] Economic Conditions - Japan's GDP grew modestly in Q2, aided by tourism, while manufacturing activity remained restrained [5] - The People's Bank of China cut key lending rates in July to address weaknesses in the real estate sector and sluggish consumer demand, with Q2 GDP growth at 5.2% year over year [5] Investment Strategy - The MSCI EAFE Value Index outperformed the MSCI EAFE Growth Index by over 500 basis points in Q3, with value stocks leading growth by more than 1,300 basis points year to date [6] - The ClearBridge International Growth Strategy maintained pace with its core MSCI EAFE benchmark, with sector positioning in IT and financials creating headwinds [12] Company Performance - London Stock Exchange faced a decline due to AI concerns impacting its desktop and data business, while Adyen's revenue missed expectations [13] - Banco Santander was acquired for its streamlined operations and cost-cutting measures, expected to improve profitability [14] - HSBC is well-positioned for growth in Asian wealth management, benefiting from inflows of mainland Chinese money [15] - KBC Group's strong capital position allows for capital distributions or acquisitions, with growing assets under management [16] Sector Contributions - Health care sector saw solid contributions, particularly from European biotechs Argenx and UCB, driven by strong sales and positive clinical trial results [20] - The strategy expanded into the Chinese biotechnology sector with the purchase of WuXi AppTec, known for efficient drug development [21] Portfolio Adjustments - The strategy added 10 positions while exiting 13, with significant purchases in financials and health care, including Prysmian, which is poised for growth in the power cables industry [22] - Softbank trades at a discount to its NAV, holding stakes in key technology companies [23] - Celestica is positioned for growth in AI infrastructure, with expected annual revenue growth of over 20% [24] Outlook - The regions of investment are making progress on growth and equity-friendly policies, with forecasts for double-digit EPS growth in the pan-European Stoxx 600 [27] - Emerging markets are outperforming developed markets, with a focus on China’s growth potential in AI and biotechnology [28][32]